Biotherapeutic agents comprising recombinant PAP and PAP mutants
US6146628A · kind A · utility
11Cited by
7References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 11, 1995 |
| Grant date | Nov 14, 2000 |
| Priority date | — |
| Expiry date | Jul 11, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Biotherapeutic agents are provided which comprise recombinant PAP or a biologically equivalent variant or mutant thereof, linked to a targeting moiety which are effective for the treatment of certain human diseases. The invention further provides a process for producing the biotherapeutic agents as well as a method which utilizes the disclosed biotherapeutic agents to systemically treat cancer patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.